Halozyme Therapeutics Incorporate.../ US40637H1095 /
| 2024-05-28 5:29:24 PM | Chg. -0.4300 | Volume | Bid5:29:24 PM | Ask5:29:24 PM | High | Low |
|---|---|---|---|---|---|---|
| 43.3900USD | -0.98% | 209,505 Turnover: 6.45 mill. |
43.3400Bid Size: 300 | 43.3900Ask Size: 300 | 43.9650 | 43.0500 |
Business description
-
Management board & Supervisory board
| CEO |
|---|
| Helen Torley |
| Management board |
| Nicole LaBrosse, Mark Snyder, Michael J. LaBarre, Chris Wahl, Cortney Caudill, Tram Bui, Gary Grote, Amy Fox, Steve Knowles, Christopher Bryant, Kristin Schwartzbauer |
| Supervisory board |
| Jeffrey W. Henderson, Jean-Pierre Bizzari, Barbara Duncan, Matthew L. Posard, Connie L. Matsui, Moni Miyashita, Bernadette Connaughton, Helen Torley |
